Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI

Functional MRI may identify critical windows of opportunity for drug delivery and distinguish between early treatment responders and non-responders. Using diffusion-weighted, dynamic contrast-enhanced, and dynamic susceptibility contrast MRI, as well as pro-angiogenic and pro-inflammatory blood mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, K. Ina, Vakulenko-Lagun, Bella, Emblem, Kyrre E., Ou, Yangming, Da, Xiao, Betensky, Rebecca A., Kalpathy-Cramer, Jayashree, Duda, Dan G., Jain, Rakesh K., Chi, Andrew S., Plotkin, Scott R., Batchelor, Tracy T., Sorensen, Gregory, Rosen, Bruce R., Gerstner, Elizabeth R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244161/
https://www.ncbi.nlm.nih.gov/pubmed/30459364
http://dx.doi.org/10.1038/s41598-018-34820-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244161/
https://www.ncbi.nlm.nih.gov/pubmed/30459364
http://dx.doi.org/10.1038/s41598-018-34820-x

Ejemplares similares